Considering that a strong expression of HDAC1 was correlated with poor prognosis in cancer patients [42,43], and that HDAC1 is also overexpressed in cancer stem cells and modulates their function [44], the inhibition of HDAC1 could be an important strategy in cancer treatment. This evidence concerns the gene HDAC1 and cancer.